About
Our guest Dr. Faisal Khan from the University of Calgary will show how Trusight™ Tumor 170 (TST170) powered by the SOPHiA DDM™ Platform removes complexity from NGS analysis and variant interpretation while optimizing performance across all variants types.

Our Oncology Product Manager Marián Novak will then make an exciting announcement and offer a sneak peek into a new addition to the SOPHiA portfolio, which maximizes the utility of CGP.

Disclaimer notice:
The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.
The opinions expressed during this presentation are these of the speaker and may not represent the opinions of SOPHiA GENETICS.
SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at support@sophiagenetics.com to obtain the appropriate product information for your country of residence.
on-demand webinar
Presenters
1605820554-dcd7ba52b71ca6e7
Faisal M. Khan, PhD, D(ABHI)
Associate Professor – University of Calgary
1605820541-a3024736c291a41d
Marián Novak, PhD
Product Manager – SOPHiA GENETICS
Register To Watch Recording
Full name*
Email Address*
Company*
Job Title*
City*
Country*
Area of interest
Marketing Permission
SOPHiA GENETICS will use the information you provide on this form to be in touch with you and to provide updates and marketing. By checking this box, you agree on receiving emails from SOPHiA GENETICS. We will not share or sell your personal information. For more information, please read our privacy policy. You can unsubscribe anytime by clicking the unsubscribe link in the footer of our emails, or by contacting us at info@sophiagenetics.com
✓ Yes, I consent to receiving emails*
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.
Powered by BigMarker